Lista de obras - Francis Berenbaum - Dominio Público Uruguay

A reference case for economic evaluations in osteoarthritis: an expert consensus article from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

artículo científico publicado en 2014

Broad-spectrum antiviral activity of naproxen: from Influenza A to SARS-CoV-2 Coronavirus

scientific article published on 02 May 2020

Calprotectin alone is not sufficient to predict response to methotrexate in early ACR/EULAR 2010 rheumatoid arthritis: Analysis of the ESPOIR cohort

scientific article published on 17 July 2019

Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Biomarkers and Frailty

artículo científico publicado en 2015

Can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on epidemiology and phenotype of osteoarthritis

artículo científico publicado en 2015

Characterization of diabetic osteoarthritic cartilage and role of high glucose environment on chondrocyte activation: toward pathophysiological delineation of diabetes mellitus-related osteoarthritis.

artículo científico publicado en 2015

Collection and management of selected comorbidities and their risk factors in chronic inflammatory rheumatic diseases in daily practice in France

artículo científico publicado en 2016

Deep phenotyping of osteoarthritis: a step forward

artículo científico publicado en 2018

EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases

artículo científico publicado en 2019

Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

artículo científico publicado en 2021

Erratum to: Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis.

artículo científico publicado en 2017

Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial

artículo científico publicado en 2009

Festina lente: hydroxychloroquine, covid-19 and the role of the rheumatologist

scientific article published on 15 April 2020

French law: what about a reasoned reimbursement of serum vitamin D assays?

artículo científico publicado en 2016

Gut microbiota and osteoarthritis management: An expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO)

scientific article published on 19 August 2019

How to define responders in osteoarthritis

artículo científico publicado en 2013

Immune response profiling of patients with spondyloarthritis reveals signalling networks mediating TNF-blocker function in vivo

scientific article published on 02 December 2020

Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial

scientific article published on 24 November 2018

Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA).

artículo científico publicado en 2014

Increased prevalence and severity of radiographic hand osteoarthritis in patients with HIV-1 infection associated with metabolic syndrome: data from the cross-sectional METAFIB-OA study

artículo científico publicado en 2016

Metabolic stress-induced joint inflammation and osteoarthritis

artículo científico

Mobile Health Apps for Self-Management of Rheumatic and Musculoskeletal Diseases: Systematic Literature Review

scientific article published on 26 November 2019

Modern-day environmental factors in the pathogenesis of osteoarthritis

artículo científico publicado en 2018

Needs, Experiences, and Views of People With Rheumatic and Musculoskeletal Diseases on Self-Management Mobile Health Apps: Mixed Methods Study

artículo científico publicado en 2020

Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis

artículo científico publicado en 2018

Potentialisation de la fluindione et de la warfarine par la dexaméthasone dans le myélome multiple et l'amylose AL

artículo científico publicado en 2007

Potentiation of fluindione or warfarin by dexamethasone in multiple myeloma and AL amyloidosis.

artículo científico publicado en 2007

Report from the Hand Osteoarthritis Working Group at OMERACT 2018: Update on Core Instrument Set Development ⬇️

article

Response to: 'Does the prevalence of radiographic hand osteoarthritis in patients with HIV-1 infection increase or not?' by Luo et al

artículo científico publicado en 2016

Response to: 'Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis' by Singer et al

scientific article published on 05 August 2020

Response to: 'Use of tanezumab for patients with hip and knee osteoarthritis with reference to a randomised clinical trial by Berenbaum and colleagues' by Riddle and Perera

scientific article published on 18 May 2020

Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period

scientific article published on 31 March 2020

Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19

artículo científico publicado en 2020

TGFβi is involved in the chondrogenic differentiation of mesenchymal stem cells and is dysregulated in osteoarthritis

scientific article published on 28 November 2018

Tackling osteoarthritis during COVID-19 pandemic

scientific article published on 28 September 2020

[Weakening osteopathies, chronic kidney disease, malabsorption, biological anomalies of calium/phosphorus metabolism: appropriate indications for a reasoned reimbursment of serum vitamin D measurement]

scientific article published on 01 July 2014

Lista de obras de Francis Berenbaum

A reference case for economic evaluations in osteoarthritis: an expert consensus article from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

Broad-spectrum antiviral activity of naproxen: from Influenza A to SARS-CoV-2 Coronavirus

Calprotectin alone is not sufficient to predict response to methotrexate in early ACR/EULAR 2010 rheumatoid arthritis: Analysis of the ESPOIR cohort

Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Biomarkers and Frailty

Can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on epidemiology and phenotype of osteoarthritis

Characterization of diabetic osteoarthritic cartilage and role of high glucose environment on chondrocyte activation: toward pathophysiological delineation of diabetes mellitus-related osteoarthritis.

Collection and management of selected comorbidities and their risk factors in chronic inflammatory rheumatic diseases in daily practice in France

Deep phenotyping of osteoarthritis: a step forward

EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases

Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

Erratum to: Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis.

Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial

Festina lente: hydroxychloroquine, covid-19 and the role of the rheumatologist

French law: what about a reasoned reimbursement of serum vitamin D assays?

Gut microbiota and osteoarthritis management: An expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO)

How to define responders in osteoarthritis

Immune response profiling of patients with spondyloarthritis reveals signalling networks mediating TNF-blocker function in vivo

Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial

Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA).

Increased prevalence and severity of radiographic hand osteoarthritis in patients with HIV-1 infection associated with metabolic syndrome: data from the cross-sectional METAFIB-OA study

Metabolic stress-induced joint inflammation and osteoarthritis

Mobile Health Apps for Self-Management of Rheumatic and Musculoskeletal Diseases: Systematic Literature Review

Modern-day environmental factors in the pathogenesis of osteoarthritis

Needs, Experiences, and Views of People With Rheumatic and Musculoskeletal Diseases on Self-Management Mobile Health Apps: Mixed Methods Study

Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis

Potentialisation de la fluindione et de la warfarine par la dexaméthasone dans le myélome multiple et l'amylose AL

Potentiation of fluindione or warfarin by dexamethasone in multiple myeloma and AL amyloidosis.

Report from the Hand Osteoarthritis Working Group at OMERACT 2018: Update on Core Instrument Set Development ⬇️

Response to: 'Does the prevalence of radiographic hand osteoarthritis in patients with HIV-1 infection increase or not?' by Luo et al

Response to: 'Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis' by Singer et al

Response to: 'Use of tanezumab for patients with hip and knee osteoarthritis with reference to a randomised clinical trial by Berenbaum and colleagues' by Riddle and Perera

Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period

Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19

TGFβi is involved in the chondrogenic differentiation of mesenchymal stem cells and is dysregulated in osteoarthritis

Tackling osteoarthritis during COVID-19 pandemic

[Weakening osteopathies, chronic kidney disease, malabsorption, biological anomalies of calium/phosphorus metabolism: appropriate indications for a reasoned reimbursment of serum vitamin D measurement]